Canada's Strategy for Patient-Oriented Research (SPOR) SPOR Networks in Chronic Disease

Page created by Helen Hill
 
CONTINUE READING
Canada’s Strategy for Patient-
      Oriented Research (SPOR)

SPOR Networks in Chronic Disease

           To join the audio portion of this webinar,
                 please dial 1-877-413-4788,
                    Conference ID: 9485483
CORE ELEMENTS OF SPOR

     Support for People and Patient-Oriented
     Research and Trials (SUPPORT) Units

     SPOR Networks

     Capacity development

     Improving the clinical trials environment

     Patient engagement
       To join the audio portion of this webinar,
             please dial 1-877-413-4788,
                Conference ID: 9485483
SPOR Networks
National collaborations of patients, health professionals, decision
makers, health researchers and other stakeholders to generate
evidence and innovations designed to improve patient health and health
care systems

               To join the audio portion of this webinar,
                     please dial 1-877-413-4788,
                        Conference ID: 9485483
SPOR Networks in Chronic Disease

This funding opportunity will provide support for the
development and implementation of SPOR Networks in non-
communicable Chronic Diseases. For the purpose of this
opportunity, non-communicable chronic disease is defined as
a long-term disease that is not passed from one person to
another; it evolves over time, often progressing in severity.
Although a non-communicable chronic disease may be
prevented and can often be controlled, it is rarely cured.

             To join the audio portion of this webinar,
                   please dial 1-877-413-4788,
                      Conference ID: 9485483
Focus of the Networks

 Anchored on the challenges in Valley 1 research as it bridges to
  Valley 2.
 First-in-human and beyond research in non-communicable
  chronic diseases that have resulted in areas of high disease
  burden.
 Networks are strongly encouraged to explore the opportunities
  for impact across multiple non-communicable chronic diseases.
 No more than one network will be funded in any particular focus
  area.
 Successful networks are expected to include relevant
  international collaborations.

              To join the audio portion of this webinar,
                    please dial 1-877-413-4788,
                       Conference ID: 9485483
Objectives

The primary objective of the opportunity will be to translate
existing and new knowledge generated by basic biomedical,
clinical, and population health research into testing of
innovations that can improve clinical science and practice and
foster policy changes, leading to transformative and
measureable improvements in patient health outcomes, and
in efficiency and effectiveness healthcare delivery within five
years.

             To join the audio portion of this webinar,
                   please dial 1-877-413-4788,
                      Conference ID: 9485483
Objectives
Network applicants will be expected to show that the planned
program of research and knowledge translation will have a
significant impact on non-communicable chronic diseases and their
co-morbidities by:

 Addressing patient-oriented research priorities and developing an
  interdisciplinary nation-wide agenda of outcomes-oriented
  research.
 Accelerating the translation of existing and new knowledge
  generated by basic biomedical, clinical, and population health
  research into clinical science and practice and policy applications.
 Strengthening the capacity to conduct patient-oriented research
  through an integrated multidisciplinary program that provides
  unique and innovative training and mentoring opportunities.
 Fostering the development and implementation of evidence-
  informed and gender-responsive practices, policies, services,
  products and   programs to improve patient outcomes, access to
              To join the audio portion of this webinar,
  care and quality,please
                       efficiency     and effectiveness of health care.
                            dial 1-877-413-4788,
                    Conference ID: 9485483
Process and Timeline
Phase      Major Step             Key Points                            Timeline
  Important
Phase       dates:
      I Registration              •    Administrative only and will     December 2014
                                       be used to facilitate reviewer   (Deadline 2014-12-02)
                                       recruitment

           Letter of Intent       •    Reviewed by an international     January –
                                       panel of experts
                                                                        March 2015
                                  •    Top 20 in the fundable range     (Deadline 2015-01-13)
                                       will be provided with a $50K
                                       development grant and will be
                                       invited to a strengthening
                                       workshop

Phase II   Strengthening          •    Mandatory for all successful     Spring 2015
                                       LOIs
           Workshop(s)
                                  •    Workshop to help strengthen
                                       applications and encourage
                                       dialogue between applicants

Phase III Full Application        •    Full applications submitted      October 2015 –
                                       and reviewed
                                                                        January 2016
                                  •    Four distinct chronic disease    (Deadline 2015-10-15)
                                       networks are funded
                 To join the audio portion of this webinar,
                       please dial 1-877-413-4788,
                          Conference ID: 9485483
Funds Available

 Each successful network will receive up to $12,500,000 over five
  years from CIHR.

 Up to 20 Development Grants will be funded through the Letter of
  Intent stage.
    • Each Development Grant will have a maximum value of
      $50,000.
    • Partner funds are NOT required at this stage.

 Up to 4 Networks will be funded through the Full Application
  stage.
    • CIHR will provide up to $12.45M over five years per Network.
    • Funds must be matched 1:1 with non-federal sources of
      funding.
               To join the audio portion of this webinar,
                     please dial 1-877-413-4788,
                        Conference ID: 9485483
Funds Available

 Funding from an international source that does not flow or is not
  made accessible to a Canadian component of the network is not
  eligible to be counted toward the 1:1 matching requirement.

 Clinical trials are welcomed as a component of a network’s
  proposed program of research.

                To join the audio portion of this webinar,
                      please dial 1-877-413-4788,
                         Conference ID: 9485483
Eligibility

  The Nominated Principal Applicant must be one of the following:
     • An independent researcher affiliated with a CIHR eligible
       institution.
     • A knowledge user affiliated with a CIHR eligible institution.

  Each network must include distinct representatives from each of
   the following groups (i.e., one individual representing one group
   or discipline – a minimum of six individuals, including the
   Nominated Principal Applicant):

     • Researchers (minimum of three and each from a different
       discipline)
     • Health care professionals
     • Patients/family representatives/informal care providers
     • Health policy makers

               To join the audio portion of this webinar,
                     please dial 1-877-413-4788,
                        Conference ID: 9485483
Eligibility

  The network must demonstrate that it will be pan-Canadian in
   scope, i.e., that it includes Principal Applicants (key members),
   from a minimum of one province or territory in three of the
   following four regions:

     East – includes Newfoundland and Labrador, Nova
     Scotia, Prince Edward Island and New Brunswick
     Central – includes Quebec, Ontario and Manitoba
     West – includes Saskatchewan, Alberta and British
     Columbia
     North – includes Nunavut, Northwest Territories and
     Yukon

               To join the audio portion of this webinar,
                     please dial 1-877-413-4788,
                        Conference ID: 9485483
Performance Measurement

 Each network will be expected to be outcomes driven, with
  clearly defined goals and associated metrics to measure
  progress. CIHR will require funded networks to provide annual
  reporting on agreed upon performance measures.

 The network will be required to participate in any other evaluation
  or performance measurement activities deemed necessary by
  CIHR.

              To join the audio portion of this webinar,
                    please dial 1-877-413-4788,
                       Conference ID: 9485483
LOI Evaluation Criteria Categories

1.   Vision, rationale, priorities and added-value
2.   Potential for transformative impact
3.   Patient-oriented research program
4.   Strength of the team
5.   Patient-oriented research training and mentoring strategy
6.   Knowledge translation plan
7.   Partnership plan
8.   Governance

               To join the audio portion of this webinar,
                     please dial 1-877-413-4788,
                        Conference ID: 9485483
Application Process

Step 1 - Registration: by email to lisa.lemieux@cihr-irsc.gc.ca
 Names and institutions of all applicants known at the time of
  registration.
 Chronic disease(s) that will be the focus of the research and
  known objectives of research.
 Keywords that will inform the areas of expertise needed to recruit
  reviewers.

Registration is mandatory to be able to submit a Letter of Intent.

              To join the audio portion of this webinar,
                    please dial 1-877-413-4788,
                       Conference ID: 9485483
Application Process

Step 2 - Letter of Intent: on ResearchNet

Please note:
 A maximum of six (6) Canadian Academic Common CV or a
   Knowledge User CV will be accepted; core team must be
   identified as Principal Knowledge users or Principal applicant and
   must include at least one (1) leader from each of the four
   stakeholder groups

 Key participants that fall in the Patient/family
  representatives/informal care providers stakeholder group are
  required to provide testimonials (max 2 pages each) describing
  their relevant lived experiences in the context of the application

  Further details on the Strengthening Workshop and the Full
  Application process will be released in the coming months.
              To join the audio portion of this webinar,
                    please dial 1-877-413-4788,
                       Conference ID: 9485483
For more information:

       For more information, the full funding
         opportunity can be found on the
          Funding Opportunity Database

For questions on CIHR funding guidelines, how to apply, and the
peer review process contact:
Lisa Lemieux, Program Delivery Coordinator
Telephone: 613-948-2398
Email: lisa.lemieux@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:
Erica Dobson, Associate
Telephone: 613-946-7656
Email: erica.dobson@cihr-irsc.gc.ca

              To join the audio portion of this webinar,
                    please dial 1-877-413-4788,
                       Conference ID: 9485483
You can also read